Skip to content
6 physician-led programs. Know your costs before you begin.See what we treat

Vayra Weight

Weight care, guided by a doctor.

A doctor reviews your health, then prescribes brand-name GLP-1 medicine if it is right for you.

FDA-approved medication. Every medication in this program is FDA-approved for its labelled use. Dispensed as the branded product from Novo Nordisk or Eli Lilly.

A woman walking out of her front door with a canvas tote

AI-generated portrayal. Prescription treatment through Vayra requires a clinical evaluation and is not guaranteed.

Rx only. See side effects of GLP-1s, including the Boxed Warning, in Vayra’s GLP-1 safety information.

  • Licensed doctors in 40+ states
  • No insurance needed
  • Use your FSA or HSA
  • Your health info stays private (HIPAA)

What’s included.

In this program

  • Doctor visit and ongoing review
  • Baseline and follow-up lab tracking
  • Brand-name GLP-1 medicine, if prescribed
  • Optional meal-replacement add-on

With every plan

  • A licensed physician who reviews your care
  • Follow-up visits based on your plan
  • Lab orders, interpretation, and tracking over time
  • No insurance billing, no paperwork

What's your weight goal?

Pick the goal that fits you. Your doctor reviews it with you before anything is prescribed.

Care that keeps going.

Your doctor reviews your labs on a schedule set by your plan and adjusts your treatment as you go.

  1. Questions
  2. Doctor
  3. Treatment
  4. Check-in

Your price, shown first.

Your plan covers doctor care and the lab testing in it. Medicine is priced separately, and you see your total before you pay.

The brand
FDA-approved brand
  • Wegovy (semaglutide)
  • Zepbound (tirzepatide)
  • Mounjaro (tirzepatide)
Brand only

Weight care at Vayra uses FDA-approved branded GLP-1 medication only. There is no Vayra house-brand GLP-1, and Vayra does not offer compounded semaglutide or tirzepatide.

Your starting cost

From $278/mo in total: your care membership plus the lowest-priced medication option, if prescribed. Your physician confirms your medication, dose, and price before you begin.

See pricing by plan
Read important safety information

Choose your plan

How it works.

About 8 minutes of health questions. Free, and nothing to pay yet.

AI-generated portrayal. Prescription treatment through Vayra requires a clinical evaluation and is not guaranteed.

Important safety information

GLP-1 receptor agonists, including semaglutide (the active ingredient in branded products such as Wegovy® and Ozempic®), tirzepatide (Zepbound® and Mounjaro®), and liraglutide (Saxenda® and Victoza®), carry an FDA boxed warning for the risk of thyroid C-cell tumors, including medullary thyroid carcinoma (MTC). These medications are contraindicated in patients with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Additional clinically significant warnings include acute pancreatitis, gallbladder disease, hypoglycemia (particularly when combined with insulin or sulfonylureas), acute kidney injury, and potential worsening of diabetic retinopathy in patients with type 2 diabetes. A Vayra physician will review your complete medical history, current medications, and family history before determining whether GLP-1 therapy is clinically appropriate.

Talk to a Vayra physician about whether GLP-1 therapy is right for you.

Common questions

A man tying his running shoes on his front steps

Next program

Vayra Vital

Testosterone care, by your levels.

Learn more

AI-generated portrayal. Prescription treatment through Vayra requires a clinical evaluation and is not guaranteed.

Trademark attribution

Wegovy® and Saxenda® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. Vayra is not affiliated with or endorsed by Novo Nordisk or Eli Lilly. All third-party trademarks are the property of their respective owners.

Start in 8 minutes.

Free to start. Nothing to pay until you pick a plan.

AI-generated portrayal. Prescription treatment through Vayra requires a clinical evaluation and is not guaranteed.